A Plaque Test Study With LEO 35299 in Psoriasis Vulgaris
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the anti-psoriatic effect of LEO 35299 in different
formulations, compared to Daivonex® ointment and Daivonex® ointment vehicle, using the
psoriasis plaque test modified from the method developed by KJ Dumas and JR Scholtz.